About this trial
Patients with advanced chronic kidney disease awaiting deceased-donor kidney transplantation frequently experience progressive functional decline, frailty, reduced mobility, and poor quality of life while on the transplant waiting list. Although multimodal prehabilitation programs based on exercise, nutritional optimization, and psychological support have shown promising benefits in major surgery, their implementation in kidney transplant candidates remains limited due to barriers related to accessibility, fatigue, transportation, and treatment burden.
This randomized single-center clinical trial aims to evaluate the feasibility, adherence, and effectiveness of a multimodal prehabilitation program in patients awaiting deceased-donor kidney transplantation, comparing an in-person supervised model with a remote home-based model supported by a digital platform. The primary outcome will be the change in functional capacity measured by the 6-Minute Walk Test (6MWT). Secondary outcomes include physical activity level, frailty, nutritional status, kidney disease-specific quality of life (KDQOL-36), postoperative recovery quality (QoR-15), postoperative complications, and program adherence.
The study seeks to generate clinically applicable evidence regarding the implementation and scalability of remote prehabilitation strategies in patients with advanced chronic kidney disease, with the potential to improve accessibility, sustainability, and perioperative outcomes in kidney transplantation.
Eligibility criteria
Qualifiers
Adults aged 18 years or older.
Patients with advanced chronic kidney disease on the waiting list for deceased-donor kidney transplantation.
Ability to perform moderate-intensity physical exercise.
Able and willing to provide written informed consent.
Disqualifiers
Absolute contraindication to physical exercise.
Severe cognitive impairment limiting participation in the intervention or assessments.
Active infection at the time of enrollment.
Clinically unstable medical condition.
Trial design
Treatments tested in this trial
- In-Person Multimodal Prehabilitation
- Remote Multimodal Prehabilitation